Immunology

Showing page 159 of 175

  • INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T cell Activity Against Global SARS-CoV-2 Variants

    1. Viviane M. Andrade
    2. Aaron Christensen-Quick
    3. Joseph Agnes
    4. Jared Tur
    5. Charles Reed
    6. Richa Kalia
    7. Idania Marrero
    8. Dustin Elwood
    9. Katherine Schultheis
    10. Mansi Purwar
    11. Emma Reuschel
    12. Trevor McMullan
    13. Patrick Pezzoli
    14. Kim Kraynyak
    15. Albert Sylvester
    16. Mammen P. Mammen
    17. Pablo Tebas
    18. J. Joseph Kim
    19. David B. Weiner
    20. Trevor R.F. Smith
    21. Stephanie J. Ramos
    22. Laurent M. Humeau
    23. Jean D. Boyer
    24. Kate E. Broderick
    1 evaluations Latest evaluation on Published on

  • Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV

    1. Aljawharah Alrubayyi
    2. Ester Gea-Mallorquí
    3. Emma Touizer
    4. Dan Hameiri-Bowen
    5. Jakub Kopycinski
    6. Bethany Charlton
    7. Natasha Fisher-Pearson
    8. Luke Muir
    9. Annachiara Rosa
    10. Chloe Roustan
    11. Christopher Earl
    12. Peter Cherepanov
    13. Pierre Pellegrino
    14. Laura Waters
    15. Fiona Burns
    16. Sabine Kinloch
    17. Tao Dong
    18. Lucy Dorrell
    19. Sarah Rowland-Jones
    20. Laura E. McCoy
    21. Dimitra Peppa
    1 evaluations Latest evaluation on Published on

  • Blunted Fas signaling favors RIPK1-driven neutrophil necroptosis in critically ill COVID-19 patients

    1. Tiziano A. Schweizer
    2. Srikanth Mairpady Shambat
    3. Clément Vulin
    4. Sylvia Hoeller
    5. Claudio Acevedo
    6. Markus Huemer
    7. Alejandro Gomez-Mejia
    8. Chun-Chi Chang
    9. Jeruscha Baum
    10. Sanne Hertegonne
    11. Eva Hitz
    12. Daniel A. Hofmaenner
    13. Philipp K. Buehler
    14. Holger Moch
    15. Reto A. Schuepbach
    16. Silvio D. Brugger
    17. Annelies S. Zinkernagel
    1 evaluations Latest evaluation on Published on

  • Development and pre-clinical evaluation of Newcastle disease virus-vectored SARS-CoV-2 intranasal vaccine candidate

    1. Manolo Fernandez Díaz
    2. Katherine Calderon
    3. Aldo Rojas-Neyra
    4. Vikram N. Vakharia
    5. Ricardo Choque-Guevara
    6. Angela Montalvan
    7. Astrid Poma-Acevedo
    8. Dora Rios-Matos
    9. Andres Agurto-Arteaga
    10. María de Grecia Cauti-Mendoza
    11. Norma Perez-Martinez
    12. Gisela Isasi-Rivas
    13. Luis Tataje-Lavanda
    14. Miryam Palomino
    15. Henri Bailón
    16. Yacory Sernaque-Aguilar
    17. Freddy Ygnacio-Aguirre
    18. Manuel Criollo-Orozco
    19. Edison Huaccachi-Gonzalez
    20. Elmer Delgado-Ccancce
    21. Doris Villanueva-Pérez
    22. Ricardo Montesinos-Millan
    23. Kristel Gutiérrez-Manchay
    24. Katherine Pauyac-Antezana
    25. Ingrid Ramirez-Ortiz
    26. Stefany Quiñones-Garcia
    27. Yudith Cauna-Orocollo
    28. Katherine Vallejos-Sánchez
    29. Angela A. Rios-Angulo
    30. Dennis Núñez-Fernández
    31. Mario I. Salguedo-Bohorquez
    32. Julio Ticona
    33. Manolo Fernández Sánchez
    34. Paquita García
    35. Eliana Icochea
    36. Luis Guevara
    37. Mirko Zimic
    38. for the COVID-19 Working Group in Perú
    1 evaluations Latest evaluation on Published on

  • Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants

    1. Hyeseon Cho
    2. Kristina Kay Gonzales-Wartz
    3. Deli Huang
    4. Meng Yuan
    5. Mary Peterson
    6. Janie Liang
    7. Nathan Beutler
    8. Jonathan L. Torres
    9. Yu Cong
    10. Elena Postnikova
    11. Sandhya Bangaru
    12. Chloe Adrienna Talana
    13. Wei Shi
    14. Eun Sung Yang
    15. Yi Zhang
    16. Kwanyee Leung
    17. Lingshu Wang
    18. Linghang Peng
    19. Jeff Skinner
    20. Shanping Li
    21. Nicholas C. Wu
    22. Hejun Liu
    23. Cherrelle Dacon
    24. Thomas Moyer
    25. Melanie Cohen
    26. Ming Zhao
    27. F. Eun-Hyung Lee
    28. Rona S. Weinberg
    29. Iyadh Douagi
    30. Robin Gross
    31. Connie Schmaljohn
    32. Amarendra Pegu
    33. John R. Mascola
    34. Michael Holbrook
    35. David Nemazee
    36. Thomas F. Rogers
    37. Andrew B. Ward
    38. Ian A. Wilson
    39. Peter D. Crompton
    40. Joshua Tan
    1 evaluations Latest evaluation on Published on

  • Optimization of an LNP-mRNA vaccine candidate targeting SARS-CoV-2 receptor-binding domain

    1. Kouji Kobiyama
    2. Masaki Imai
    3. Nao Jounai
    4. Misako Nakayama
    5. Kou Hioki
    6. Kiyoko Iwatsuki-Horimoto
    7. Seiya Yamayoshi
    8. Jun Tsuchida
    9. Takako Niwa
    10. Takashi Suzuki
    11. Mutsumi Ito
    12. Shinya Yamada
    13. Tokiko Watanabe
    14. Maki Kiso
    15. Hideo Negishi
    16. Burcu Temizoz
    17. Hirohito Ishigaki
    18. Yoshinori Kitagawa
    19. Cong Thanh Nguyen
    20. Yasushi Itoh
    21. Fumihiko Takeshita
    22. Yoshihiro Kawaoka
    23. Ken J. Ishii
    1 evaluations Latest evaluation on Published on

  • N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

    1. Matthew McCallum
    2. Anna De Marco
    3. Florian Lempp
    4. M. Alejandra Tortorici
    5. Dora Pinto
    6. Alexandra C. Walls
    7. Martina Beltramello
    8. Alex Chen
    9. Zhuoming Liu
    10. Fabrizia Zatta
    11. Samantha Zepeda
    12. Julia di Iulio
    13. John E. Bowen
    14. Martin Montiel-Ruiz
    15. Jiayi Zhou
    16. Laura E. Rosen
    17. Siro Bianchi
    18. Barbara Guarino
    19. Chiara Silacci Fregni
    20. Rana Abdelnabi
    21. Shi-Yan Caroline Foo
    22. Paul W. Rothlauf
    23. Louis-Marie Bloyet
    24. Fabio Benigni
    25. Elisabetta Cameroni
    26. Johan Neyts
    27. Agostino Riva
    28. Gyorgy Snell
    29. Amalio Telenti
    30. Sean P.J. Whelan
    31. Herbert W. Virgin
    32. Davide Corti
    33. Matteo Samuele Pizzuto
    34. David Veesler
    2 evaluations Latest evaluation on Published on
Previous Next